Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...

With rapid improvements in AI, things are quickly moving away from AI chatbots to action-driven AI agents. AI agents are ready to change our everyday lives and how we interact with services. They ...

In this week’s edition of InnovationRx, we look at the biotech deal frenzy, Recursion’s incoming CEO, the infant formula botulism outbreak, and more. To get it in your inbox, subscribe here. Merck ...

Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...

Flamekeeper. Mirrorwalker. Echo architect. These are some of the fantastical titles that people have assigned themselves after days, weeks, or months of simulated conversations with AI chatbots. David ...

Great leadership doesn’t just happen in boardrooms or business settings. From little league coaching and community initiatives to family moments and encounters with service providers, powerful ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

The Table API enables a programmatic way of developing, testing, and submitting Flink pipelines for processing data streams. Streams can be finite or infinite, with insert-only or changelog data. The ...

Sept 2 (Reuters) - Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results, in line with an FDA push to reduce animal testing in ...